Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • News Feature
  • Published:

Fresh from the biotech pipeline 2011

Subjects

An Erratum to this article was published on 10 April 2012

This article has been updated

Abstract

Drug approvals were up in 2011, reversing the trend of the last decade. Jim Kling reports.

This is a preview of subscription content, access via your institution

Access options

Rent or buy this article

Prices vary by article type

from$1.95

to$39.95

Prices may be subject to local taxes which are calculated during checkout

Figure 1

Change history

  • 10 April 2012

    In the print version of this article, the title reads “Fresh from the pipeline 2011.” It should read “Fresh from the biotech pipeline—2011.” The title has been corrected in the HTML and PDF versions of the article before online publication.

References

  1. Loeb, J. Comparison of US and European biosimilar regulation and litigation. BioLawGics <http://www.biolawgics.com/fda-approval/comparison-of-us-and-european-biosimilar-regulation-and-litigation/> (March 29, 2011)

  2. Thomaselli, R. FDA's social media guidelines befuddle big pharma. Ad Age Digital <http://adage.com/article/digital/fda-s-social-media-guidelines-befuddle-big-pharma/231855/> (Dec. 30, 2011).

  3. Rader, R. FDA biopharmaceutical product approvals and trends: 2011. BIOPHARMA: Biopharmaceutical Products in the US and European Markets. <http://www.biopharma.com/approvals_2011.html>

  4. DeFrancesco, L. Nat. Biotechnol. 29, 851–852 (2011).

    Article  CAS  Google Scholar 

  5. Stohl, W. & Hilbeck, D.M. Nat. Biotechnol. 30, 69–77 (2012).

    Article  CAS  Google Scholar 

  6. Moran, N. Nat. Biotechnol. 30, 3–5 (2012).

    Article  CAS  Google Scholar 

  7. Robert, C. N. Engl. J. Med. 364, 2517–2526 (2011).

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Kling, J. Fresh from the biotech pipeline 2011. Nat Biotechnol 30, 128–131 (2012). https://doi.org/10.1038/nbt.2111

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nbt.2111

This article is cited by

Search

Quick links

Nature Briefing: Translational Research

Sign up for the Nature Briefing: Translational Research newsletter — top stories in biotechnology, drug discovery and pharma.

Get what matters in translational research, free to your inbox weekly. Sign up for Nature Briefing: Translational Research